Stiftingtalstraße 14 | 8010 Graz, Austria

Cycuria to Present at the AACR Annual Meeting 2026 in San Diego

We are excited to share that our Founder, 𝗣𝗿𝗼𝗳. 𝗗𝗿. Philipp Jost, will be presenting at the 𝗔𝗔𝗖𝗥 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲 in San Diego this April. His oral presentation will highlight new data on our lead program, showcasing Cycuria’s approach to targeting cancer cell vulnerabilities and advancing next-generation therapeutics for patients with high unmet need. […]

Cycuria to Present at the Startup Spotlight at BIO-Europe Spring

Cycuria has been selected to present at the Startup Spotlight Stage during the upcoming BIO-Europe Spring partnering conference ! Our presentation will showcase Cycuria’s pioneering approach to decoupling toxicity from long-lasting efficacy in the treatment of hematological cancers through our first-in-class, protein-based targeted therapy . We will share our progress to date and our vision […]

Meet Cycuria at ASH Annual Meeting 2024 in San Diego

Cycuria will be attending the upcoming American Society of Hematology (ASH) Annual Meeting in San Diego from December 7- December 10. We look forward to exciting and stimulating discussions with scientists, clinicians and industry professionals who are shaping the future of cancer care. See you there!